| Model Number |
EGIA30AVM |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Codes |
Hemorrhage/Blood Loss/Bleeding (1888); Tissue Breakdown (2681)
|
| Date of Event |
07/22/2025
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
It was reported that intraoperatively when firing the reloads, the surgeon observed excessive bleeding than normal.No intervention was done or required.
|
| |
|
Additional Manufacturer Narrative
|
|
D10 concomitant products: egia60avm, egia60avm egia 60 artic vasc med sulu (lot #: p5d1167).Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
It was reported that during the gastric bypass, the surgeon observed excessive bleeding when firing the 30mm.Reload in the gastrojejunal anastomosis and when firing the 60mm.Reload in the jejunal transection.Manual suturing and clips were used to stop the bleeding.The patient bled but less than 500cc.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information: b5, g3, h6.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information: g3, h3, h6 h3 evaluation summary: medtronic conducted an investigation based upon all information received.The involved device was not returned.However, a video was provided.Visual inspection noted one monitor displaying a staple line.Blood could be seen egressing from the staple line.The reload was not visible in the video.It was reported that during the gastric bypass, the surgeon observed excessive bleeding when firing the 30-millimeter (mm) reload in the gastrojejunal anastomosis and when firing the 60 mm reload in the jejunal transection.The reported issue was confirmed.The most likely cause could not be established from the information available.The manufacturing records for each device are thoroughly reviewed prior to release to ensure that it meets all medtronic quality specifications.A secondary review of the device history records found no potentially contributing factors.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Search Alerts/Recalls
|